Tapestry Pharmaceuticals, Inc. to Host Conference Call on November 5th to Discuss Third Quarter 2007 Financial Results

BOULDER, Colo., Oct. 29 /PRNewswire-FirstCall/ -- Tapestry Pharmaceuticals, Inc. announced today that it will host a conference call on Monday, November 5, 2007 at 12:00 p.m. Eastern Time (10:00 a.m. Mountain Time) to review the Company's third quarter 2007 financial results and provide a company update. The Company will issue a press release regarding its second quarter financial results on the same day, prior to the conference call.

To participate in the conference call, please dial 800-798-2864 (domestic) or 617-614-6206 (international) and reference the access code 50821900. A replay of the call will be available from 2:00 p.m. Eastern Time on November 5, 2007 until November 12, 2007 at midnight Eastern Time. To access the replay, please dial 888-286-8010 (domestic) or 617-801-6888 (international) and reference the access code 55489394. A live audio webcast of the call will also be available on the "Investors" section of the Company's website, http://www.tapestrypharma.com. An archived webcast will be available on the Tapestry website for approximately 30 days after the event.

About Tapestry Pharmaceuticals, Inc.

Tapestry Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development of proprietary therapies for the treatment of cancer. For more information about Tapestry and its technologies, visit Tapestry's website at http://www.tapestrypharma.com.

glink@tapestrypharma.comlilian@sternir.comtapestry@schwartz-pr.com

CONTACT: Gordon Link, Senior Vice President, Chief Financial Officer of
Tapestry Pharmaceuticals, Inc., +1-303-516-8500, glink@tapestrypharma.com;
or Investor, Laura Perry of Stern Investor Relations, Inc.,
+1-212-362-1200, lilian@sternir.com, or Media, Dana Conti of Schwartz
Communications, Inc., +1-781-684-0770, tapestry@schwartz-pr.com, both for
Tapestry Pharmaceuticals, Inc.

Web site: http://www.tapestrypharma.com/